Decoding the WHO Global Tuberculosis Report 2024: A Critical Analysis of Global and Chinese Key Data 深入解读WHO《2024年全球结核病报告》 作者: Zhi Chen , Tao Wang , Jingli Du , Lin Sun , Guirong Wang , Ruizi Ni , Yajing An , Xueting Fan , Yufeng Li , Rui Guo , Lirong Mao , Wei ...
WHO世界卫生组织:2024年全球结核病报告(英文版).pdf 下载文档资源简介 > The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This...
resistantinfections.Immediateglobal•2023Antibacterialagentsinclinicalandpreclinical coordinationandcooperationisessentialdevelopment:anoverviewandanalysis.Geneva:World HealthOrganization;2024. toenhanceinnovativeRD,improveAMR •WHOBacterialPriorityPathogensList,2024:bacterial ...
“The WHO Global Tuberculosis Report is a stark reminder that tuberculosis is now killing nearly twice as many people as COVID-19 every day,” David Dowdy (Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA) told The Lancet Microbe. He added, “The major challenges in fight...
世界卫生组织(WHO):2023年全球结核病报告(英文版)(75页).pdf 1、globalTUBERCULOSIS2023REPORTiGlobaltuberculosisreport2023Global tuberculosis report 2023ISBN 978-92-4-008385-1(electronic version)ISBN 978-92-4-008386-8(print version)World Health Organization 2023Some rights reserved.This work is available ...
GLOBAL TUBERCULOSIS CONTROL WHO REPORT 2000 WORLD HEALTH ORGANIZATIONDiseases, Communicable
This report is WHO's 13th annual report on global tuberculosis (TB) control in a series that started in 1997. The report presents WHO's latest assessment o... WH Organization - http://www.who.int/tb/publications/global_report/2009/en/index.html 被引量: 1710发表: 2009年 WHO's 2013 gl...
ofthegeneralassemblyonthefightagainsttuberculosis[EB/OL].Ne wYork:UnitedNations,2023[2024-05-27].https://digitallibrary.un. org/record/4022582. [5]WorldHealthOrganitation.Globaltuberculosisreport2023[EB/OL]. Geneva:WorldHealthOrganitation,2023[2024-05-27].https://digita ...
正如WHO BPPL-2024所强调的,CRKP和CRAB感染治疗面临药物选择有限的挑战,既往我国临床主要依赖被称为“老三剑客”的替加环素、多黏菌素类药物和头孢他啶/阿维巴坦。然而,这些药物在临床应用中也存在一些问题:替加环素在血清和肺泡上皮衬液中的分布浓度并不理想[8-9],药敏折点的界定存在争议[10],且提高剂量可能...
Moran N. WHO issues another gloomy tuberculosis report. Nat Med. 1996;2(4):377.Mooran, N. WHO issues another gloomy tuberculosis report. Nat. Med. 1996, 2, 377.Moran N. WHO issues another gloomy tuberculosis report. Nature Med 1996;2: 377....